首页> 外文期刊>药学学报(英文版) >VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
【24h】

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

机译:VEGF-B抗体和白细胞介素-22融合蛋白通过抑制脂质积累和炎症反应来改善糖尿病肾病

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《药学学报(英文版)》 |2021年第1期|127-142|共16页
  • 作者单位

    Department of Nephrology Changhai Hospital Second Military Medical University Shanghai 200433 China;

    Department of Nephrology Changhai Hospital Second Military Medical University Shanghai 200433 China;

    Department of Nephrology Shanghai Yangpu Hospital of TCM Shanghai 200090 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Nephrology Changhai Hospital Second Military Medical University Shanghai 200433 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Ophthalmology Stanford University School of Medicine Palo Alto CA 94304 USA;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Nephrology Changhai Hospital Second Military Medical University Shanghai 200433 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

    Department of Nephrology Changhai Hospital Second Military Medical University Shanghai 200433 China;

    Department of Biological Medicines Fudan University School of Pharmacy Shanghai 201203 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号